Abstract
A 42-year-old female with Crohn’s disease who had previously undergone multiple surgical interventions developed marked hypocalcemia, which could not be resolved with calcium administration. Markedly reduced serum magnesium levels were also observed. After intravenous magnesium administration, serum calcium levels rapidly normalized. In addition, the plasma levels of intact parathyroid hormone increased immediately after magnesium administration. These data strongly suggest that hypocalcemia resulted from disturbance of appropriate parathyroid hormone secretion caused by hypomagnesemia. After introduction of infliximab therapy, her abdominal symptoms and endoscopic findings improved, and serum calcium and magnesium levels stabilized within the normal range without magnesium administration.
Similar content being viewed by others
References
Harries AD, Brown R, Heatley RV, et al. Vitamin D status in Crohn’s disease: association with nutrition and disease activity. Gut. 1985;26:1197–203.
Driscoll RH Jr, Meredith SC, Sitrin M, et al. Vitamin D deficiency and bone disease in patients with Crohn’s disease. Gastroenterology. 1982;83:1252–8.
Fukumoto S, Namba N, Ozono K, et al. Causes and differential diagnosis of hypocalcemia: recommendation proposed by expert panel supported by ministry of health, labour and welfare. Jpn Endocr J. 2008;55:787–94.
Cholst IN, Steinberg SF, Tropper PJ, et al. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med. 1984;310:1221–5.
Suh SM, Csima A, Fraser D. Pathogenesis of hypocalcemia in magnesium depletion. Normal end-organ responsiveness to parathyroid hormone. J Clin Invest. 1971;50:2668–78.
Gerlach K, Morowitz DA, Kirsner JB. Symptomatic hypomagnesemia complicating regional enteritis. Gastroenterology. 1970;59:567–74.
Kelly AP, Robb BJ, Gearry RB. Hypocalcaemia and hypomagnesaemia: a complication of Crohn’s disease. N Z Med J. 2008;121:77–9.
Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn’s disease. Gastroenterology. 1990;99:956–63.
Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn’s disease activity index. National Co-operative Crohn’s disease Study. Gastroenterology. 1976;70:439–44.
de Dombal FT, Softley A. IOIBD report no 1: observer variation in calculating indices of severity and activity in Crohn’s disease. International Organisation for the Study of Inflammatory Bowel Disease. Gut. 1987;28:474–81.
Flatman PW. Magnesium transport across cell membranes. J Membr Biol. 1984;80:1–14.
Elin RJ. Magnesium: the fifth but forgotten electrolyte. Am J Clin Pathol. 1994;102:616–22.
Quamme GA. Renal handling of magnesium: Drug and hormone interactions. Magnesium. 1986;5:248–72.
Schweigel M, Martens H. Magnesium transport in the gastrointestinal tract. Fr Biosci. 2000;5:D666–77.
Fine KD, Santa Ana CA, Porter JL, et al. Intestinal absorption of magnesium from food and supplements. J Clin Invest. 1991;88:396–402.
Tong GM, Rude RK. Magnesium deficiency in critical illness. J Intensive Care Med. 2005;20:3–17.
Behar J. Magnesium absorption by the rat ileum and colon. Am J Physiol. 1974;227:334–40.
Brannan PG, Vergne-Marini P, Pak CY, et al. Magnesium absorption in the human small intestine: results in normal subjects, patients with chronic renal disease, and patients with absorptive hypercalciuria. J Clin Invest. 1976;57:1412–8.
Frizzell RA, Schultz SG. Ionic conductances of extracellular shunt pathway in rabbit ileum: influence of shunt on transmural sodium transport and electrical potential differences. J Gen Physiol. 1972;59:318–46.
Miranda SC, Ribeiro ML, Ferriolli E, et al. Hypomagnesemia in short bowel syndrome patients. Sao Paulo Med J. 2000;118:169–72.
Disclosures
Conflict of Interest:
Akane Mukai, Shuji Yamamoto, and Kazuyoshi Matsumura declare that they have no conflict of interest.
Human/Animal Rights:
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008(5).
Informed Consent:
Informed consent was obtained from the patient for being included in the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mukai, A., Yamamoto, S. & Matsumura, K. Hypocalcemia secondary to hypomagnesemia in a patient with Crohn’s disease. Clin J Gastroenterol 8, 22–25 (2015). https://doi.org/10.1007/s12328-014-0544-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-014-0544-9